Exosomal circRNAs: new players in colorectal cancer

被引:0
|
作者
Faezeh Vakhshiteh
Shokoufeh Hassani
Navid Momenifar
Fatemeh Pakdaman
机构
[1] Tehran University of Medical,Nanotechnology Research Centre, Faculty of Pharmacy
[2] Sciences,Toxicology and Diseases Group (TDG), Pharmaceutical Sciences Research Center (PSRC)
[3] The Institute of Pharmaceutical Sciences (TIPS),Department of Toxicology and Pharmacology, School of Pharmacy
[4] Tehran University of Medical Sciences,Human and Animal Cell Bank, Iranian Biological Resource Center (IBRC)
[5] Tehran University of Medical Sciences,Department of Genetics, Faculty of Science
[6] ACECR,undefined
[7] University of Shahrekord,undefined
来源
Cancer Cell International | / 21卷
关键词
Exosome; circRNA; Colorectal cancer;
D O I
暂无
中图分类号
学科分类号
摘要
Colorectal cancer (CRC) is one of the most malignant cancer types, characterized by elevated mortality rate and treatment resistance. Despite the progress achieved in the explanation of the molecular basis of the disease as well as introducing potential biomarkers in the clinical practice, further investigation is essential to identify innovative molecules that contribute to colorectal carcinogenesis. Circular RNAs (circRNAs) are a novel and unexplored RNA type, associated with various human pathological conditions. Recently, circRNAs have been identified to be enriched and stable in exosomes and can exert their functions when exosomes reach neighboring or distant cells. Increasing evidence indicates that these so called exosomal circRNAs (exo-circRNAs) act as signaling molecules to regulate cancer proliferation, metastasis, and sensitivity to radio- and chemotherapy. This review aims to discuss the latest progress in exo-circRNAs studies in CRC with an emphasis on their potential as promising diagnostic molecular markers and therapeutic targets.
引用
收藏
相关论文
共 50 条
  • [31] Exosomal noncoding RNAs in colorectal cancer
    Wu, Qingbin
    Liu, Wenrong
    Wang, Jin
    Zhu, Lei
    Wang, Ziqiang
    Peng, Yong
    CANCER LETTERS, 2020, 493 : 228 - 235
  • [32] Emerging roles of exosomal circRNAs in non-small cell lung cancer
    Hongyuan Yin
    Jiayi Shi
    Shaoling Li
    Qianhui You
    Huici Zhu
    Chinying Koo
    Baonian Liu
    Likun Hou
    Chunyan Wu
    Journal of Translational Medicine, 23 (1)
  • [33] The potential role of exosomal circRNAs in the tumor microenvironment: insights into cancer diagnosis and therapy
    Li, Juan
    Zhang, Guo
    Liu, Chen-Guang
    Xiang, Xiaoqiang
    Le, Minh T. N.
    Sethi, Gautam
    Wang, Lingzhi
    Goh, Boon-Cher
    Ma, Zhaowu
    THERANOSTICS, 2022, 12 (01): : 87 - 104
  • [34] Exosomes and Exosomal circRNAs: The Rising Stars in the Progression, Diagnosis and Prognosis of Gastric Cancer
    Lu, Ling
    Fang, Shikun
    Zhang, Yue
    Jin, Longtao
    Xu, Wenrong
    Liang, Zhaofeng
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 8121 - 8129
  • [35] Exosomal LncRNAs and CircRNAs in lung cancer: Emerging regulators and potential therapeutic targets
    Li, Xia
    Wu, Yunbing
    Jin, Yue
    NON-CODING RNA RESEARCH, 2024, 9 (04): : 1069 - 1079
  • [36] CircRNAs: promising factors for regulating angiogenesis in colorectal cancer
    Guo, Xiaohu
    Chang, Xingyu
    Wang, Zheyuan
    Jiang, Chenjun
    Wei, Zhengang
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2022, 24 (09): : 1673 - 1681
  • [37] CircRNAs in colorectal cancer: potential biomarkers and therapeutic targets
    Yuying Zhang
    Jingyan Luo
    Weikang Yang
    Wen-Chu Ye
    Cell Death & Disease, 14
  • [38] CircRNAs in colorectal cancer: potential biomarkers and therapeutic targets
    Zhang, Yuying
    Luo, Jingyan
    Yang, Weikang
    Ye, Wen-Chu
    CELL DEATH & DISEASE, 2023, 14 (06)
  • [39] CircRNAs: promising factors for regulating angiogenesis in colorectal cancer
    Xiaohu Guo
    Xingyu Chang
    Zheyuan Wang
    Chenjun Jiang
    Zhengang Wei
    Clinical and Translational Oncology, 2022, 24 : 1673 - 1681
  • [40] Three CircRNAs Function as Potential Biomarkers for Colorectal Cancer
    Zhang, Jinling
    Cai, Ang
    Zhao, Yu
    CLINICAL LABORATORY, 2020, 66 (12) : 2405 - 2412